Plus   Neg

Quest Diagnostics Continues To Post Steep Loss In Late-Day Trading

Shares of Quest Diagnostics Inc. (DGX) continue to see substantial weakness in late-day trading on Thursday after falling sharply early in the session. After hitting a two-year intraday low, Quest Diagnostics is currently down by 9.2 percent.

Quest Diagnostics initially came under pressure after the lab testing services provider lowered its full-year earnings and revenue forecast.

The company said it now expects full-year earnings greater than $6.30 per share on revenues of approximately $7.57 billion compared to its previous forecast for earnings of $6.53 to $6.60 per share on revenues of around $7.62 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Facebook has removed four separate networks of accounts, pages and groups for engaging in co-ordinated inauthentic behavior on Facebook and Instagram. These networks originated from Iran and Russia and primarily targeted the US, North Africa and Latin America. These networks often posted on both sides of political issues including topics like US elections, environmental issues, racial tensions. While reporting financial results for the third quarter on Tuesday, Lockheed Martin Corp. (LMT) raised its earnings and net sales guidance for the full-year 2019, and initiated net sales outlook for the full-year 2020. For fiscal 2019, the company now expects earnings of about $21.55 per share, up... Consumer goods giant Procter & Gamble on Tuesday reported a 12 percent increase in profit for the first quarter of fiscal 2020 from last year, driven by an increase in net sales and operating margin. Both revenue and core earnings per share for the quarter beat analysts' estimates. Looking ahead, the company raised its earnings and revenue growth guidance for the full-year 2020.
Follow RTT